Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Collegium Pharmaceutical, Inc. (COLL) · oqro.io/stocks/COLL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Traded Aug 29, 2025 · filed 5 days laterNot reported under a pre-arranged trading plan
Collegium Pharmaceutical's and Chief Medical Officer sold $672K of Collegium Pharmaceutical shares. The filing does not indicate a pre-arranged trading plan.
Traded Aug 13, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Collegium Pharmaceutical sold $946K of Collegium Pharmaceutical shares. The filing does not indicate a pre-arranged trading plan.
0 open-market purchases and 8 open-market sales by insiders of COLL between Jan 27, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Feb 24, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
John Gordon Freund, Director, May 18, 2026, about $681. Sold 11 days after the company's previous earnings release on 2026-05-07Form 4
John Gordon Freund, Director, May 15, 2026, about $143K. Sold 8 days after the company's previous earnings release on 2026-05-07Form 4
Nancy Lurker, Director, May 13, 2026, about $162K. Sold 6 days after the company's previous earnings release on 2026-05-07Form 4
Garen G Bohlin, Director, May 11, 2026, about $323K. Sold 4 days after the company's previous earnings release on 2026-05-07Form 4
, EVP & General Counsel, Mar 18, 2026, about $488K. Sold 20 days after the company's previous earnings release on 2026-02-26
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies